---
title: "嵐圖汽車 CEO 盧放：內卷之下沒有贏家更沒有未來，堅決反對無序價格戰"
description: "嵐圖汽車 CEO 盧放在 2025 中國汽車重慶論壇上表示，新能源汽車行業面臨同質化競爭和非理性競爭的挑戰。他強調反對無序價格戰，認為在內卷中沒有贏家，未來需通過高水平技術創新和合理競爭來創造正向價值，實現全價值鏈共贏和可持續發展。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/243563076.md"
published_at: "2025-06-07T09:32:32.000Z"
---

# 嵐圖汽車 CEO 盧放：內卷之下沒有贏家更沒有未來，堅決反對無序價格戰

> 嵐圖汽車 CEO 盧放在 2025 中國汽車重慶論壇上表示，新能源汽車行業面臨同質化競爭和非理性競爭的挑戰。他強調反對無序價格戰，認為在內卷中沒有贏家，未來需通過高水平技術創新和合理競爭來創造正向價值，實現全價值鏈共贏和可持續發展。

嵐圖汽車 CEO 盧放在 2025 中國汽車重慶論壇表示，從跟跑到並跑，再到領跑，中國新能源汽車登頂全球。但新能源汽車快速發展背後多重新的挑戰：同質化競爭加劇，用户體驗有待提升，行業 “內卷” 帶來的非理性競爭。他認為，要堅持創造正向價值，通過高水平技術創新走出 “內卷”。內卷之下沒有贏家，更沒有未來。他提出三點舉措：遵從產業發展正確邏輯，堅決反對無序的價格戰；通過合理競爭促進行業發展，為用户與社會創造正向價值；通過技術創新，實現全價值鏈共贏和可持續發展。

### Related Stocks

- [00489.HK - 東風集團股份](https://longbridge.com/zh-HK/quote/00489.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Dongfeng Motor Group Announces Fulfilment of All Merger Pre-Conditions | Dongfeng Motor Group (Wuhan) Investment Company Limited has met all pre-conditions for its merger with Dongfeng Motor Gr | [Link](https://longbridge.com/zh-HK/news/275671043.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Lenovo Expands Global R&D with New AI Centers in UK, Saudi Arabia, and Israel | Lenovo Group Limited is expanding its global R&D presence by establishing new AI innovation centers in the UK (Edinburgh | [Link](https://longbridge.com/zh-HK/news/276047612.md) |
| Trump's affordability agenda has a car problem it needs to fix | The Trump administration's affordability agenda overlooks the auto market, which is crucial for American families. A rec | [Link](https://longbridge.com/zh-HK/news/275946150.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。